Egetis Therapeutics (Sweden) Technical Analysis
| EGTX Stock | SEK 5.60 0.04 0.71% |
As of the 27th of November, Egetis Therapeutics shows the Coefficient Of Variation of 24783.51, downside deviation of 3.28, and Mean Deviation of 2.78. Egetis Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Egetis Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Egetis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EgetisEgetis |
Egetis Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Egetis Therapeutics Technical Analysis
The output start index for this execution was four with a total number of output elements of fifty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Egetis Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Egetis Therapeutics Trend Analysis
Use this graph to draw trend lines for Egetis Therapeutics AB. You can use it to identify possible trend reversals for Egetis Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Egetis Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Egetis Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Egetis Therapeutics AB applied against its price change over selected period. The best fit line has a slop of 0 , which means Egetis Therapeutics AB will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.17, which is the sum of squared deviations for the predicted Egetis Therapeutics price change compared to its average price change.About Egetis Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Egetis Therapeutics AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Egetis Therapeutics AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Egetis Therapeutics price pattern first instead of the macroeconomic environment surrounding Egetis Therapeutics. By analyzing Egetis Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Egetis Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Egetis Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Egetis Therapeutics November 27, 2024 Technical Indicators
Most technical analysis of Egetis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Egetis from various momentum indicators to cycle indicators. When you analyze Egetis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0112 | |||
| Market Risk Adjusted Performance | 0.0713 | |||
| Mean Deviation | 2.78 | |||
| Semi Deviation | 3.15 | |||
| Downside Deviation | 3.28 | |||
| Coefficient Of Variation | 24783.51 | |||
| Standard Deviation | 4.16 | |||
| Variance | 17.32 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.65) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0613 | |||
| Maximum Drawdown | 28.58 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 6.76 | |||
| Downside Variance | 10.73 | |||
| Semi Variance | 9.91 | |||
| Expected Short fall | (3.69) | |||
| Skewness | 1.21 | |||
| Kurtosis | 4.6 |
Additional Tools for Egetis Stock Analysis
When running Egetis Therapeutics' price analysis, check to measure Egetis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Egetis Therapeutics is operating at the current time. Most of Egetis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Egetis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Egetis Therapeutics' price. Additionally, you may evaluate how the addition of Egetis Therapeutics to your portfolios can decrease your overall portfolio volatility.